ترکیب فناوری نانو با عوامل هدفمند عروقی برای درمان موثر سرطان
Combination of nanotechnology with vascular targeting agents for effective cancer therapy
نویسندگان: رعنا جهانبان اسفهلان , خالد صیدی , بهناز بنی محمد شتربانی , علی جهانبان اسفهلان
کلمات کلیدی: angiogenesis; hypoxia; microenvironment; nanomedicine; signaling pathways
نشریه: 19614 , 233 , 4 , 2018
| نویسنده ثبت کننده مقاله |
رعنا جهانبان اسفهلان |
| مرحله جاری مقاله |
تایید نهایی |
| دانشکده/مرکز مربوطه |
دانشکده علوم نوین پزشکی |
| کد مقاله |
62142 |
| عنوان فارسی مقاله |
ترکیب فناوری نانو با عوامل هدفمند عروقی برای درمان موثر سرطان |
| عنوان لاتین مقاله |
Combination of nanotechnology with vascular targeting agents for effective cancer therapy |
| ناشر |
5 |
| آیا مقاله از طرح تحقیقاتی و یا منتورشیپ استخراج شده است؟ |
خیر |
| عنوان نشریه (خارج از لیست فوق) |
|
| نوع مقاله |
Review Article |
| نحوه ایندکس شدن مقاله |
ایندکس شده سطح یک – ISI - Web of Science |
| آدرس لینک مقاله/ همایش در شبکه اینترنت |
http://onlinelibrary.wiley.com/doi/10.1002/jcp.26051/abstract |
| As a young science, nanotechnology promptly integrated into the current oncology practice. Accordingly, various nanostructure particles were developed to reduce drug toxicity and allow the targeted delivery of various diagnostic and therapeutic compounds to the cancer cells. New sophisticated nanosystems constantly emerge to improve the performance of current anticancer modalities. Targeting tumor vasculature is an attractive strategy to fight cancer. Though the idea was swiftly furthered from basic science to the clinic, targeting tumor vasculature had a limited potential in patients, where tumors relapse due to the development of multiple drug resistance and metastasis. The aim of this review is to discuss the advantages of nanosystem incorporation with various vascular targeting agents, including (i) endogen anti-angiogenic agents; (ii) inhibitors of angiogenesis-related growth factors; (iii) inhibitors of tyrosine kinase receptors; (iv) inhibitors of angiogenesis-related signaling pathways; (v) inhibitors of tumor endothelial cell-associated markers; and (vi) tumor vascular disrupting agents. We also review the efficacy of nanostructures as natural vascular targeting agents. The efficacy of each approach in cancer therapy is further discussed. |
| نام فایل |
تاریخ درج فایل |
اندازه فایل |
دانلود |
| 10.1002@jcp.26051.pdf | 1396/10/25 | 818270 | دانلود |